A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

(AUAER) is proud to announce a collaboration with Pfizer Medical Grants & Partnerships (GMGP) to offer $1.5 million in grant funding to urology and urologic oncology health institutions and ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

—For patients with biochemical recurrent prostate cancer, prostate-specific membrane antigen positron emission tomography has the potential to improve long-term outcomes. A new study tested this ...

The limitations of traditional imaging methods drive clinicians to expand the use of advanced imaging techniques in the staging of high-risk prostate cancer. Once such emerging modality is whole ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

This joint Request for Proposals (RFP) is designed to address critical gaps in patient care for individuals with advanced prostate cancer (APC) and support novel quality improvement, solution ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.